nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

6. Nanogels-Based Mucosal Vaccines

verfasst von : Sergio Rosales-Mendoza, Omar González-Ortega

Erschienen in: Nanovaccines

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Innovative vaccines are required to fight human and animal diseases. Improved immunogenicity, safety, easy administration, and low cost are among the innovations that are pursued in this field. Nanogels are materials with attractive features to meet these requirements; they consist of solid, jelly like materials produced by crosslinking of synthetic or natural polymers (or a combination of both) with a high water-holding capacity. Herein, the state of the art of nanogels-based vaccines is provided. Synthesis and functionalization methods for nanogels are described. Thus far, several groups have evaluated nanogels as vaccine delivery vehicles leading to promising data for nanovaccines against cancer, obesity, and infectious diseases. The most advanced candidates are nanovaccines against cancer, based on cholesteryl pullulan nanogels, that have been evaluated in clinical trials revealing proper immunogenicity and safety. The key perspectives for this topic include expanding the assessment of mucosal vaccines and implementing green syntheses approaches, which could lead to lower production cost and enhanced safety.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Silica-Based Mucosal Nanovaccines

Nächstes Kapitel Carbon Nanotubes-Based Mucosal Vaccines

Akiyoshi K, Yamaguchi S, Sunamoto J (1991) Self-aggregates of hydrophobic polysaccharide derivatives. Chem Lett 20(7):1263–1266CrossRef

Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J (1993) Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 26(12):3062–3068CrossRef

Alshehri R, Ilyas AM, Hasan A, Arnaout A, Ahmed F, Memic A (2016) Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity. J Med Chem 59(18):8149–8167CrossRef

Ayame H, Morimoto N, Akiyoshi K (2008) Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug Chem 19(4):882–890CrossRef

Azegami T, Yuki Y, Sawada S, Mejima M, Ishige K, Akiyoshi K, Itoh H, Kiyono H (2017) Nanogel-based nasal ghrelin vaccine prevents obesity. Mucosal Immunol 10:1351–1360CrossRef

Cheng KC, Demirci A, Catchmark JM (2011) Pullulan: biosynthesis, production, and applications. Appl Microbiol Biotechnol 92(1):29CrossRef

Chiu M, Bao C, Sadarangani M (2019) Dilemmas with rotavirus vaccine: the neonate and immunocompromised. Pediatr Infect Dis J 38.(6S Suppl 1:S43–S46CrossRef

Feng JL, Qi JR, Yin SW, Wang JM, Guo J, Weng JY, Liu QR, Yang XQ (2015) Fabrication and characterization of stable soy β-conglycinin-dextran core-shell nanogels prepared via a self-assembly approach at the isoelectric point. J Agric Food Chem 63(26):6075–6083CrossRef

Fukuyama Y, Yuki Y, Katakai Y, Harada N, Takahashi H, Takeda S, Mejima M, Joo S, Kurokawa S, Sawada S, Shibata H, Park EJ, Fujihashi K, Briles DE, Yasutomi Y, Tsukada H, Akiyoshi K, Kiyono H (2015) Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunol 8:1144–1153CrossRef

Gheibi-Hayat SM, Darroudi M (2019) Nanovaccine: a novel approach in immunization. J Cell Physiol 234(8):12530–12536CrossRef

Gu XG, Schmitt M, Hiasa A, Nagata Y, Ikeda H, Sasaki Y, Akiyoshi K, Sunamoto J, Nakamura H, Kuribayashi K, Shiku H (1998) A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. Cancer Res 58(15):3385–3390

Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 48(30):5418–5429CrossRef

Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott AM, Murphy R, Hoffman EW, Old LJ, Katayama N, Shiku H (2008) Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci 99:601–607CrossRef

Kendre PN, Satav TS (2019) Current trends and concepts in the design and development of nanogel carrier systems. Polym Bull 76(3):1595–1617CrossRef

Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, Okumura S, Imai H, Shiraishi T, Masuya M, Nishikawa M, Sunamoto J, Akiyoshi K, Kanematsu T, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H (2006) HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin Cancer Res 12:7397–7405CrossRef

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H (2013) Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae. Infect Immun 81:1625–1634CrossRef

Krauss S, Zhang CY, Lowell BB (2005) The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6(3):248CrossRef

Kumari M, Survase SA, Singhal RS (2008) Production of schizophyllan using Schizophyllum commune NRCM. Bioresour Technol 99(5):1036–1043CrossRef

Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T, Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, Miyahara Y, Kageyama S, Shiku H, Hirano S (2016) Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel. Oncol Lett 12:4493–4504CrossRef

Layton JB, Butler AM, Panozzo CA, Brookhart MA (2018) Rotavirus vaccination and short-term risk of adverse events in US infants. Paediatr Perinat Epidemiol 32(5):448–457CrossRef

Li D, Kordalivand N, Fransen MF, Ossendorp F, Raemdonck K, Vermonden T, Hennink WE, Van Nostrum CF (2015) Reduction-sensitive dextran nanogels aimed for intracellular delivery of antigens. Adv Funct Mater 25(20):2993–3003CrossRef

Li D, Sun F, Bourajjaj M, Chen Y, Pieters EH, Chen J, van den Dikkenberg JB, Lou B, Camps MG, Ossendorp F, Hennink WE, Vermonden T, van Nostrum CF (2016) Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds. Nanoscale 8:19592–19604CrossRef

Lopez-Chaves C, Soto-Alvaredo J, Montes-Bayon M, Bettmer J, Llopis J, Sanchez-Gonzalez C (2017) Gold nanoparticles: distribution, bioaccumulation and toxicity. In vitro and in vivo studies. Nanomedicine 14:1):1–1)12

Matyjaszewski K, Davis TP (2002) Handbook of radical polymerization. Wiley, HobokenCrossRef

Miquel-Clopés A, Bentley EG, Stewart JP, Carding SR (2019) Mucosal vaccines and technology. Clin Exp Immunol 196(2):205–214

Miyamoto N, Mochizuki S, Sakurai K (2014) Enhanced immunostimulation with crosslinked CpG-DNA/β-1, 3-glucan nanoparticle through hybridization. Chem Lett 43(7):991–993CrossRef

Miyamoto N, Mochizuki S, Fujii S, Yoshida K, Sakurai K (2017) Adjuvant activity enhanced by cross-linked CpG-oligonucleotides in β-glucan nanogel and its antitumor effect. Bioconjug Chem 28:565–573CrossRef

Moad G, Solomon DH (2006) The chemistry of radical polymerization. Elsevier, Amsterdam

Muraoka D, Harada N, Hayashi T, Tahara Y, Momose F, Sawada S, Mukai SA, Akiyoshi K, Shiku H (2014) Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. ACS Nano 8:9209–9218CrossRef

Neamtu I, Rusu AG, Diaconu A, Nita LE, Chiriac AP (2017) Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv 24(1):539–557CrossRef

Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9:572–578CrossRef

Nuhn L, Vanparijs N, De Beuckelaer A, Lybaert L, Verstraete G, Deswarte K, Lienenklaus S, Shukla NM, Salyer AC, Lambrecht BN, Grooten J (2016) pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation. Proc Natl Acad Sci 113(29):8098–8103CrossRef

Nuhn L, Van Hoecke L, Deswarte K, Schepens B, Li Y, Lambrecht BN, De Koker S, David SA, Saelens X, De Geest BG (2018) Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Biomaterials 178:643–651CrossRef

Patarroyo ME, Bermúdez A, Moreno-Vranich A (2012) Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine. Expert Rev Vaccines 11(9):1057–1070CrossRef

Purwada A, Tian YF, Huang W, Rohrbach KM, Deol S, August A, Singh A (2016) Self-assembly protein nanogels for safer Cancer immunotherapy. Adv Healthc Mater 5:1413–1419CrossRef

Raemdonck K, Demeester J, De Smedt S (2009) Advanced nanogel engineering for drug delivery. Soft Matter 5(4):707–715CrossRef

Rosales-Mendoza S, Salazar-González JA, Decker EL, Reski R (2016) Implications of plant glycans in the development of innovative vaccines. Expert Rev Vaccines 15(7):915–925CrossRef

Ross AC, Chen Q, Ma Y (2011) Vitamin a and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm 86:103–126CrossRef

Sanson N, Rieger J (2010) Synthesis of nanogels/microgels by conventional and controlled radical crosslinking copolymerization. Polym Chem 1(7):965–977CrossRef

Soni KS, Desale SS, Bronich TK (2016) Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 240:109–126CrossRef

Toyoda M, Hama S, Ikeda Y, Nagasaki Y, Kogure K (2015) Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm 483:110–114CrossRef

Uthaman S, Maya S, Jayakumar R, Cho CS, Park IK (2014) Carbohydrate-based nanogels as drug and gene delivery systems. J Nanosci Nanotechnol 14(1):694–704CrossRef

Verheyen E, Delain-Bioton L, van der Wal S, el Morabit N, Barendregt A, Hennink WE, van Nostrum CF (2010) Conjugation of methacrylamide groups to a model protein via a reducible linker for immobilization and subsequent triggered release from hydrogels. Macromol Biosci 10(12):1517–1526CrossRef

Wang C, Li P, Liu L, Pan H, Li H, Cai L, Ma Y (2016) Self-adjuvanted nanovaccine for cancer immunotherapy: role of lysosomal rupture-induced ROS in MHC class I antigen presentation. Biomaterials 79:88–100CrossRef

Yadav H, Al Halabi N, Alsalloum G (2017) Nanogels as novel drug delivery systems—a review. J Pharm Pharm Res 1(1):5

Zhang X, Malhotra S, Molina M, Haag R (2015) Micro- and nanogels with labile crosslinks – from synthesis to biomedical applications. Chem Soc Rev 44:1948–1973CrossRef

Zhang MY, Guo J, Hu XM, Zhao SQ, Li SL, Wang J (2019) An in vivo anti-tumor effect of eckol from marine brown algae by improving the immune response. Food Funct 10:4361. https://doi.org/10.1039/c9fo00865aCrossRef

Zhu G, Zhang F, Ni Q, Niu G, Chen X (2017) Efficient nanovaccine delivery in cancer immunotherapy. ACS Nano 11(3):2387–2392CrossRef

Titel: Nanogels-Based Mucosal Vaccines
verfasst von: Sergio Rosales-Mendoza
Omar González-Ortega
Verlag: Springer International Publishing
Buch: Nanovaccines
Print ISBN: 978-3-030-31667-9

Electronic ISBN: 978-3-030-31668-6

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-030-31668-6_6

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht